Atorvastatin Inhibits High-Fat Diet-Induced Lipid Metabolism Disorders in Rats by Inhibiting Bacteroides Reduction and Improving Metabolism

PURPOSE: The prevalence of hyperlipidemia and related illnesses is on its rise, and atorvastatin is the frequently used hypolipidemic agent. However, there is still uncertainty about the mechanisms, especially the relationship between the lipid-lowering effect, intestinal microbiome, and metabolic p...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Huimin, Wang, Shue, Wang, Shuai, Yu, Hai, Yu, Wenhao, Ma, Xiaomin, He, Xiaodong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637332/
https://www.ncbi.nlm.nih.gov/pubmed/36349306
http://dx.doi.org/10.2147/DDDT.S379335

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637332/
https://www.ncbi.nlm.nih.gov/pubmed/36349306
http://dx.doi.org/10.2147/DDDT.S379335

Ejemplares similares